IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,400,115 | +10.0% | 3,955,029 | -0.5% | 0.01% | +11.1% |
| Q2 2023 | $163,071,807 | +12.2% | 3,974,453 | -2.3% | 0.01% | +12.5% |
| Q1 2023 | $145,399,703 | -54.4% | 4,068,334 | -51.8% | 0.01% | -11.1% |
| Q4 2022 | $318,682,788 | +91.6% | 8,437,458 | +124.3% | 0.01% | -18.2% |
| Q3 2022 | $166,347,000 | +6.9% | 3,760,955 | -10.5% | 0.01% | +22.2% |
| Q2 2022 | $155,590,000 | +4.2% | 4,202,874 | +4.3% | 0.01% | +28.6% |
| Q1 2022 | $149,295,000 | +25.6% | 4,030,646 | +3.2% | 0.01% | +16.7% |
| Q4 2021 | $118,871,000 | +0.6% | 3,906,375 | +10.9% | 0.01% | 0.0% |
| Q3 2021 | $118,105,000 | -8.4% | 3,521,314 | +9.0% | 0.01% | -14.3% |
| Q2 2021 | $128,883,000 | -15.9% | 3,230,951 | -5.2% | 0.01% | -22.2% |
| Q1 2021 | $153,294,000 | -30.7% | 3,409,571 | -12.9% | 0.01% | -35.7% |
| Q4 2020 | $221,260,000 | +31.2% | 3,913,328 | +10.1% | 0.01% | +16.7% |
| Q3 2020 | $168,680,000 | -20.3% | 3,554,894 | -1.0% | 0.01% | -20.0% |
| Q2 2020 | $211,691,000 | +15.0% | 3,590,423 | -7.8% | 0.02% | -6.2% |
| Q1 2020 | $184,056,000 | -20.8% | 3,892,894 | +1.2% | 0.02% | 0.0% |
| Q4 2019 | $232,421,000 | +6.3% | 3,847,385 | +5.4% | 0.02% | 0.0% |
| Q3 2019 | $218,718,000 | -5.1% | 3,650,783 | +1.8% | 0.02% | -5.9% |
| Q2 2019 | $230,452,000 | +11.2% | 3,585,679 | +40.4% | 0.02% | +6.2% |
| Q1 2019 | $207,234,000 | +51.2% | 2,553,088 | +0.7% | 0.02% | +33.3% |
| Q4 2018 | $137,051,000 | -11.9% | 2,535,169 | -15.9% | 0.01% | 0.0% |
| Q3 2018 | $155,501,000 | +22.0% | 3,014,716 | -1.4% | 0.01% | +9.1% |
| Q2 2018 | $127,470,000 | -2.5% | 3,059,018 | +3.2% | 0.01% | 0.0% |
| Q1 2018 | $130,701,000 | -5.6% | 2,965,247 | +7.7% | 0.01% | 0.0% |
| Q4 2017 | $138,454,000 | -7.2% | 2,752,542 | -6.4% | 0.01% | -15.4% |
| Q3 2017 | $149,153,000 | -1.1% | 2,941,821 | -0.7% | 0.01% | 0.0% |
| Q2 2017 | $150,779,000 | +12.3% | 2,963,990 | -11.3% | 0.01% | +8.3% |
| Q1 2017 | $134,285,000 | +1.3% | 3,340,471 | +20.5% | 0.01% | 0.0% |
| Q4 2016 | $132,612,000 | +1.0% | 2,772,679 | -22.7% | 0.01% | -7.7% |
| Q3 2016 | $131,339,000 | +32.8% | 3,584,604 | -15.6% | 0.01% | +18.2% |
| Q2 2016 | $98,915,000 | -19.6% | 4,246,911 | +39.8% | 0.01% | -15.4% |
| Q1 2016 | $123,010,000 | -24.3% | 3,037,388 | +15.7% | 0.01% | -27.8% |
| Q4 2015 | $162,557,000 | – | 2,624,873 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |